Results 151 to 160 of about 231,974 (295)
Translational advances in pancreatic ductal adenocarcinoma therapy
A. Hosein +3 more
semanticscholar +1 more source
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Pancreatic ductal adenocarcinoma (PDAC), which constitutes 90% of pancreatic cancers, is the fourth leading cause of cancer-related deaths in the world.
A. Adamska, A. Domenichini, M. Falasca
semanticscholar +1 more source
Objective: The aim of this study is to evaluate the prognostic significance of intraoperative peritoneal lavage cytology (PLC) in pancreatic invasive ductal adenocarcinoma.Methods: Intraoperative PLC was evaluated in 162 patients with resectable ...
Kenichi eHirabayashi +10 more
doaj +1 more source
Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models [PDF]
Beate Gündel +3 more
openalex +1 more source
Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy [PDF]
Ke Chen +9 more
openalex +1 more source
Aim Lymph node metastasis is an adverse prognostic factor in pancreatic ductal adenocarcinoma. However, it remains a challenge to predict lymph node metastasis using preoperative imaging alone.
Susumu Daibo +9 more
doaj +1 more source
Cases of pancreatic ductal adenocarcinoma with multiple masses accompanying underlying pancreatic diseases, such as intraductal papillary mucinous neoplasm, have been reported.
doaj +1 more source
Absence of an embryonic stem cell DNA methylation signature in human cancer. [PDF]
BackgroundDifferentiated cells that arise from stem cells in early development contain DNA methylation features that provide a memory trace of their fetal cell origin (FCO). The FCO signature was developed to estimate the proportion of cells in a mixture
Christensen, Brock C +5 more
core
PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma [PDF]
Kapo Saukkonen +8 more
openalex +1 more source

